Lung Cancer

Low-Dose Spiral CT Screening and Evaluation of the Solitary Pulmonary Nodule

This article will discuss current tools, approaches, and concerns regarding patient care in this setting.

Lung Cancer Screening: Has Its Time Come?

Lung Cancer

A new study sheds light on the prevalence of ALK positive non–small-cell lung cancer and suggests the best methods for screening.

Overall lung cancer rates have declined in the United States, but a new study shows how certain subtypes and demographic groups have more complicated trajectories.

Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.

Combining the EGFR inhibitors afatinib and cetuximab resulted in clinical responses among advanced lung cancer patients who had previously stopped responding to monotherapy treatment with other EGFR inhibitors.

Brachytherapy did not reduce rates of local recurrence after sublobar resection in patients with non–small-cell lung cancer, according to results of a new study.

A phase III trial of the insulin-like growth factor 1 receptor inhibitor figitumumab showed no benefit in survival outcomes when added to standard chemotherapy in patients with advanced non–small-cell lung cancer.


Subscribe to Lung Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.